Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01CA240924
National Cancer Institute
Grant: U01CA228963
U.S. Department of Defense
Grant: OC180106
Robert L. Fine Cancer Research Foundation
Grant: Robert L. Fine Cancer Research Foundation
NCI NIH HHS
Grant: K08 CA237871
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA226871
National Institutes of Health
Grant: 5U01CA228963-04
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
National Institutes of Health
Grant: 5R01CA240924-04
Reverse transcriptase inhibitor effects on the mobilome of colon cancer
FWCI
1.64
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals